Volume 94 Issue 37 | p. 13 | Concentrates
Issue Date: September 19, 2016

Catalent will buy Pharmatek Labs

Department: Business
Keywords: drug delivery, formulation, acquisition, contract manufacturing

Catalent is buying San Diego-based Pharmatek Laboratories for an undisclosed amount. The purchase will add early-stage dosage-form drug development capabilities, analytical services, and clinical-scale manufacturing to Catalent’s drug delivery and formulation business. In particular, Catalent will gain spray-drying technology and expand its ability to handle highly potent compounds. Pharmatek works on oral, injectable, and topical products for more than 100 customers, the companies say.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment